18257-89-1

Basic information

• Product Name: 1-ALLYL-3-BROMOBENZENE
• Synonyms: 1-ALLYL-3-BROMOBENZENE;3-(3-BROMOPHENYL)-1-PROPENE;3-(Prop-1-en-3-yl)bromobenzene;3-(3-Bromophenyl)prop-1-ene, 1-Allyl-3-bromobenzene, 1-Bromo-3-(prop-2-en-1-yl)benzene;3-Allylbromobenzene;3-(3-Bromophenyl)prop-1-ene, 1-Bromo-3-(prop-2-en-1-yl)benzene
• CAS NO: 18257-89-1
• Molecular Formula: C₉H₉Br
• Molecular Weight: 197.07
• Mol File: 18257-89-1.mol
• Article Data: 13

Chemical Properties

• Boiling Point: 224°Cat760mmHg
• Flash Point: 90.8°C
• Appearance: /
• Density: 1.313g/cm³
• Vapor Pressure: 0.139mmHg at 25°C
• Refractive Index: 1.55
• Sensitive: Light Sensitive
• CAS DataBase Reference: 1-ALLYL-3-BROMOBENZENE(CAS DataBase Reference)
• NIST Chemistry Reference: 1-ALLYL-3-BROMOBENZENE(18257-89-1)
• EPA Substance Registry System: 1-ALLYL-3-BROMOBENZENE(18257-89-1)

Safety Data

• Hazard Codes: Xi
• Hazardous Substances Data: 18257-89-1(Hazardous Substances Data)

Usage

General Description

1-ALLYL-3-BROMOBENZENE is a chemical compound that consists of a benzene ring with a bromine atom in the 3-position and an allyl group attached to the 1-position. It is commonly used as an intermediate in the synthesis of various organic compounds, including pharmaceuticals, agrochemicals, and fragrances. The allyl group provides a versatile reactive site for further chemical transformations, making this compound an important building block in organic synthesis. Additionally, the presence of the bromine atom makes it useful in various organic reactions, such as substitution and elimination reactions. Overall, 1-ALLYL-3-BROMOBENZENE is a valuable compound with diverse applications in chemical synthesis.

InChI:InChI=1/C9H9Br/c1-2-4-8-5-3-6-9(10)7-8/h2-3,5-7H,1,4H2

Upstream product

• 108-36-1 1,3-dibromobenzene 
• 106-95-6 allyl bromide 
• 107134-85-0 m-C₆H₄BrBCl₂ 
• 591-19-5 m-Bromoaniline 
• 762-72-1 allyl-trimethyl-silane 
• 74-85-1 ethene 
• 932-77-4 3-bromobenzyl chloride 
• 591-87-7 Allyl acetate 
• 583-53-9 2,3-dibromobenzene 
• 107134-71-4 [3-(dichloroboryl)phenyl]trimethylsilane 
• 2060-89-1 m-bis(trimethylsilyl)benzene 
• 591-18-4 1-Bromo-3-iodobenzene 

Downstream Products

• 3132-99-8 m-bromobenzoic aldehyde 
• 1589528-83-5 (E)-5-(3-bromophenyl)-2-methyl-2-nitro-1-phenylpent-4-en-1-one 
• 1442416-67-2 1-iodo-3-(3-(triisopropoxysilyl)propyl)benzene 
• 1442416-63-8 1-bromo-4-(3-(triisopropoxysilyl)propyl)benzene 
• 1442416-69-4 C₁₈H₃₁ClMgO₃Si 
• 65537-54-4 3-(3-bromophenyl)-propan-1-ol 
• 145233-30-3 3-(3-bromophenyl)-2-hydroxy-1-[1-(4-phenylpiperazinyl)]propane 
• 145233-28-9 3-(3-bromophenyl)-2-hydroxy-1-[1-(4-phenylpiperidinyl)]propane 
• 134905-92-3 Acetic acid 1-(3-bromo-benzyl)-2-(4-phenyl-piperidin-1-yl)-ethyl ester 
• 62826-43-1 2-(3-Bromo-benzyl)-oxirane 

Relevant articles and documents

ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES

A compound having a structure of the formula Ir(LA)(LB), in which LA is a bidentate, tridentate, tetradentate, pentadentate, or hexadentate ligand and LB is a monodentate, bidentate, tridentate, or tetradentate ligand, or not present, and where the total denticity of LA plus LB is 6, and LA includes at least one structure of Formula I: is disclosed as a useful phosphorescent emitter compound.

SUBSTITUTED BRIDGED UREA ANALOGS AS SIRTUIN MODULATORS

The present invention relates to novel substituted bridged urea compounds, corresponding related analogs, pharmaceutical compositions and methods of use thereof. Sirtuin-modulating compounds of the present invention may be used for increasing the lifespan of a cell, and treating and/or preventing a wide variety of diseases and disorders, which include, but are not limited to, for example, diseases or disorders related to aging or stress, diabetes, obesity, neurodegenerative diseases, cardiovascular disease, blood clotting disorders, inflammation, cancer, and/or flushing as well as diseases or disorders that would benefit from increased mitochondrial activity. The present invention also related to compositions comprising a sirtuin-modulating compound in combination with another therapeutic agent.

A new synthetic approach for functional triisopropoxyorganosilanes using molecular building blocks

We report an efficient synthetic approach for well-designed organic-bridged alkoxysilanes, which allow the formation of highly functional organosilica hybrids under mild sol-gel conditions. A series of molecular building blocks containing a triisopropoxys